Data / Form D filings / Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc.: Form D filings
Arsenal Biosciences, Inc., a biotechnology company in South San Francisco, CA, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on September 4, 2024, reports $325.4 million sold of a $325.4 million offering to 26 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 329 Oyster Point Blvd, South San Francisco, CA, 94080
- Phone
- (650) 240-8844
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1945638
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 4, 2024 | New notice | $325,352,578 | $325,352,578 | 26 | Jul 9, 2024 | sec.gov | |
| Sep 9, 2022 | New notice | $230,806,614 | $220,806,682 | $9,999,932 | 17 | Feb 10, 2022 | sec.gov |
| Sep 9, 2022 | New notice | $32,999,954 | $32,999,954 | 9 | Dec 14, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Matthew Fust | Director | |
| Valentin Barsan | Director | |
| Sean Parker | Director | |
| Brook Byers | Director | |
| James Ahlers | Executive Officer | |
| Kenneth Drazan | Executive Officer, Director | |
| Irene Pleasure | Executive Officer | |
| Beth Seidenberg | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Sep 2, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Arsenal Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.